Daishinku Q1 FY27 operating result turns to loss; net sales rise 12.8% to JPY 10.58 billion
Reuters2026/08/10 06:47- Daishinku posted Q1 net sales of JPY 10.58 billion, up 12.8% year on year, as sales increased across telecommunications, automotive, consumer, and industrial markets.
- Operating result turned to a loss of JPY 11 million from profit, due to higher gold prices and increased fixed costs.
- Ordinary profit swung to JPY 136 million, helped by JPY 177 million in foreign exchange gains.
- Loss attributable to owners of parent narrowed to JPY 77 million, as income taxes rose.
- Forecast for the year ending March 31, 2027 was maintained, targeting net sales of JPY 41 billion and profit attributable to owners of parent of JPY 100 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Crypto prices
More
